The Pink Sheet, an industry trade publication, wrote about our partnership with Sanofi, titled “Sanofi Taps Fox Foundation For Parkinson’s Drug Development.” In speaking with The Pink Sheet, Mark Fraiser, vice president of research programs, explains how this collaboration with Sanofi came about, why it’s needed, and how it can serve as model for future MJFF-industry projects.  As Mark says, “This is a good opportunity for us to shine a light on the unmet need of Parkinson’s patients with cognitive deficits.”